Copenhagen, Denmark

Henning Schou


Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1983-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Henning Schou

Introduction

Henning Schou is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmacology, particularly through his innovative work on beta-carbolin-3-carboxylic acid derivatives. With a total of 2 patents to his name, Schou's inventions have the potential to impact medical treatments.

Latest Patents

Schou's latest patents include a beta-carbolin-3-carboxylic acid derivative that is useful for treating various conditions. This derivative is characterized by the formula wherein X can be oxygen, sulfur, or NR^10, with R^10 representing hydrogen, C1-6 alkyl, C1-6 alkenyl, C3-7 cycloalkyl, or C3-7 cycloalkenyl. Additionally, another patent focuses on a beta-carbolin-3-carboxylic acid derivative that exhibits valuable pharmacological properties when administered to patients, such as humans, and has been shown to possess interesting tranquilizing activity.

Career Highlights

Throughout his career, Henning Schou has worked with prominent companies, including Ferrosan and Scherling AG. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the pharmaceutical industry.

Collaborations

Schou has collaborated with notable individuals in his field, including Claus T. Braestrup and Mogens C. Nielsen. These collaborations have further enriched his research and development efforts.

Conclusion

Henning Schou's contributions to the field of pharmacology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…